![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Dependent Increase in Cell-Surface Protein Level and Activity of Glutamate Transporter Type 3
Department of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia
Abstract
Glutamate transporters regulate extracellular concentrations of glutamate, an excitatory neurotransmitter in the central nervous system. We have shown that the commonly used anesthetic isoflurane increased the activity of glutamate transporter type 3 (excitatory amino acid transporter 3, EAAT3) possibly via a protein kinase C (PKC)-dependent pathway. In this study, we showed that isoflurane induced a time- and concentration-dependent redistribution of EAAT3 to the cell membrane in C6 glioma cells. This redistribution was inhibited by staurosporine, a pan PKC inhibitor, or by 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole (Gö6976) at a concentration that selectively inhibits conventional PKC isozymes (PKC
, -
, and -
). This isoflurane-induced EAAT3 redistribution was also blocked when the expression of PKC
but not PKC
proteins was down-regulated by the respective antisense oligonucleotides. The isoflurane-induced increase of glutamate uptake by EAAT3 was abolished by the down-regulation of PKC
expression. Immunoprecipitation with an anti-EAAT3 antibody pulled down more PKC
in cells exposed to isoflurane than in control cells. Isoflurane also increased the phosphorylated EAAT3 and the redistribution of PKC
to the particulate fraction of cells. Consistent with the results in C6 cells, isoflurane also increased EAAT3 cell-surface expression and enhanced the association of PKC
with EAAT3 in rat hippocampal synaptosomes. Our results suggest that the isoflurane-induced increase in EAAT3 activity requires an increased amount of EAAT3 protein in the plasma membrane. These effects are PKC
-dependent and may rely on the formation of an EAAT3-PKC
complex. Together, these results suggest an important mechanism for the regulation of glutamate transporter functions and expand our understanding of isoflurane pharmacology at cellular and molecular levels.
Address correspondence to: Dr. Zhiyi Zuo, Department of Anesthesiology, University of Virginia Health System, P.O. Box 800710, One Hospital Drive, Charlottesville, VA 22908-0710. E-mail: zz3c{at}virginia.edu
This article has been cited by other articles:
![]() |
Y. Huang, X. Feng, J. J. Sando, and Z. Zuo Critical Role of Serine 465 in Isoflurane-induced Increase of Cell-surface Redistribution and Activity of Glutamate Transporter Type 3 J. Biol. Chem., December 15, 2006; 281(50): 38133 - 38138. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Bickler and C. S. Fahlman The inhaled anesthetic, isoflurane, enhances Ca2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth. Analg., August 1, 2006; 103(2): 419 - 29, table of contents. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ma, S. Zheng, and Z. Zuo The Transcription Factor Regulatory Factor X1 Increases the Expression of Neuronal Glutamate Transporter Type 3 J. Biol. Chem., July 28, 2006; 281(30): 21250 - 21255. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fang, Y. Huang, and Z. Zuo Enhancement of substrate-gated Cl- currents via rat glutamate transporter EAAT4 by PMA Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1334 - C1340. [Abstract] [Full Text] [PDF] |
||||